- Investing Ideas
- /
- Global Undervalued Small Caps With Insider Buying
Global Undervalued Small Caps With Insider Buying
Results
176
34 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
176 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GABC | US$41.22 | -1.2% | 30.0% | US$1.2b | US$48.33 | PB1.7x | E23.1% | 2.8% | Banks | ||
SHBI New | US$16.26 | 3.4% | 47.5% | US$535.3m | US$18.75 | PB1x | E13.5% | 3.0% | Banks | ||
NX | US$20.56 | -6.2% | -34.4% | US$942.8m | US$36.33 | PE29.4x | E49.3% | 1.6% | Capital Goods | ||
SOIL | CA$2.10 | -4.1% | -7.5% | CA$425.4m | CA$4.42 | PE2x | E-14.9% | n/a | Energy | ||
DK | US$19.27 | 3.5% | -29.4% | US$1.2b | US$20.23 | PS0.09x | E57.3% | 5.3% | Energy | ||
CZNC New | US$21.23 | -5.1% | 10.5% | US$327.0m | US$21.00 | PB1.2x | E8.6% | 5.3% | Banks | ||
SIS | CA$18.30 | -6.0% | 11.4% | CA$1.3b | CA$25.93 | PE28.4x | E31.4% | 3.0% | Capital Goods | ||
SABR | US$3.41 | 3.0% | -15.6% | US$1.3b | US$4.40 | PS0.4x | E72.2% | 0% | Consumer Services | ||
CDXC New | US$5.69 | -3.6% | 269.5% | US$421.4m | US$7.96 | PE293.3x | E81.8% | n/a | Pharmaceuticals & Biotech | ||
NXR.UN | CA$7.40 | -2.5% | -8.9% | CA$681.7m | CA$8.89 | PB0.5x | E12.0% | 8.6% | Real Estate | ||
MUX | US$8.71 | 5.7% | 24.4% | US$458.3m | US$14.81 | PE4.5x | E-67.7% | 0% | Materials | ||
AROW New | US$27.33 | -1.2% | 14.5% | US$450.9m | US$30.25 | PB1.1x | E22.7% | 4.1% | Banks | ||
PMZ.UN | CA$14.85 | 0.1% | 9.4% | CA$1.5b | CA$18.41 | PB0.7x | E22.2% | 5.8% | Real Estate | ||
OPRX | US$5.67 | 0.2% | -62.4% | US$106.7m | US$9.64 | PS1.2x | E51.5% | n/a | Healthcare | ||
HLS | AU$1.36 | -5.2% | -5.9% | AU$987.5m | AU$1.37 | PS0.6x | E96.7% | 0% | Healthcare | ||
MARK | Rp950.00 | 1.1% | 28.4% | Rp3.6t | Rp1,250.00 | PE13x | E8.7% | 4.2% | Capital Goods | ||
2142 New | HK$4.23 | 15.6% | 157.9% | HK$3.1b | n/a | PE18.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
ABG | NOK 7.05 | 1.3% | 16.5% | NOK 3.6b | n/a | PE12.7x | n/a | 7.1% | Diversified Financials | ||
DDR | AU$8.42 | -2.7% | -24.9% | AU$1.5b | AU$10.60 | PE19x | E9.7% | 5.3% | Tech | ||
DM0 | S$0.34 | 1.5% | 4.7% | S$182.7m | n/a | PE7.9x | n/a | 4.5% | Materials | ||
2858 | HK$0.90 | 12.5% | 69.8% | HK$6.1b | HK$1.63 | PE8.2x | E19.6% | 3.2% | Diversified Financials | ||
CKF | AU$7.41 | -0.4% | -35.4% | AU$873.5m | AU$9.89 | PE17.3x | E18.4% | 3.6% | Consumer Services | ||
CTD New | AU$14.96 | -0.3% | -25.9% | AU$2.1b | AU$13.96 | PE25.1x | E12.2% | 1.9% | Consumer Services | ||
NIKL New | ₱2.54 | -3.8% | -45.7% | ₱35.4b | ₱2.83 | PE13.3x | E2.6% | 7.9% | Materials |